Clorox (CLX) hits its lowest valuation since 2014 with a secure 4.8% dividend—see why this defensive, contrarian blue chip ...
Maclean's on MSN
The end of fat
Diet drugs like Ozempic and Mounjaro are about to get a whole lot cheaper. Are we ready for a world where anyone can be thin?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results